Related Experiment Video

Updated: Oct 8, 2026

Quantitative Autonomic Testing
11:40

Quantitative Autonomic Testing

Published on: July 19, 2011

Responses to sympathetic stimulation and tilting during antihypertensive treatment with nisoldipine

F Pasanisi1, S Soro, L A Ferrara

  • 1Institute of Internal Medicine and Metabolic Diseases, Second Medical School, University of Naples, Italy.

Drugs Under Experimental and Clinical Research
|January 1, 1991
PubMed

Insights

Nisoldipine, a dihydropyridine calcium antagonist, was studied in hypertensive patients. It was found to slightly reduce blood pressure and attenuate the pressor response to sympathetic stimulation during isometric exercise.

Area of Science:

  • Cardiovascular Pharmacology
  • Hypertension Management

Background:

  • Nisoldipine is a dihydropyridine calcium antagonist.
  • It is under investigation for treating hypertension.

Purpose of the Study:

  • To assess the cardiovascular response to adrenergic stimulation (isometric exercise, cold pressor test, head-up tilt) after placebo, acute, and chronic administration of nisoldipine (5 mg or 10 mg once daily).

Main Methods:

  • Eighteen mild to moderately hypertensive patients participated.
  • Cardiovascular responses were measured following placebo, acute, and chronic nisoldipine administration.
  • Blood pressure and heart rate were recorded automatically.

Main Results:

  • Nisoldipine significantly decreased blood pressure at 2 hours post-administration.
  • Chronic 10 mg nisoldipine significantly lowered maximal blood pressure response during isometric exercise compared to placebo and 5 mg dose.
  • Cardiovascular response to cold pressor test showed a similar pattern; head-up tilt did not induce hypotension.

Conclusions:

  • Nisoldipine administration in hypertensive patients slightly attenuates the pressor response to sympathetic stimulation induced by isometric exercise.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...